VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 132 filers reported holding VBI VACCINES INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $46,000 | -41.0% | 64,985 | -33.0% | 0.00% | – |
| Q2 2022 | $78,000 | 0.0% | 97,042 | +106.4% | 0.00% | – |
| Q1 2022 | $78,000 | -49.0% | 47,012 | -28.3% | 0.00% | – |
| Q4 2021 | $153,000 | +73.9% | 65,579 | +130.6% | 0.00% | – |
| Q3 2021 | $88,000 | -85.9% | 28,440 | -84.8% | 0.00% | -100.0% |
| Q2 2021 | $625,000 | +396.0% | 186,702 | +360.6% | 0.00% | +100.0% |
| Q1 2021 | $126,000 | -13.1% | 40,534 | -23.4% | 0.00% | 0.0% |
| Q4 2020 | $145,000 | -86.4% | 52,891 | -85.8% | 0.00% | -92.9% |
| Q3 2020 | $1,068,000 | +224.6% | 373,396 | +251.8% | 0.01% | +180.0% |
| Q2 2020 | $329,000 | +53.7% | 106,127 | -76.6% | 0.01% | +150.0% |
| Q3 2019 | $214,000 | +791.7% | 453,108 | +2983.0% | 0.00% | – |
| Q4 2018 | $24,000 | -85.0% | 14,697 | -77.7% | 0.00% | -100.0% |
| Q3 2018 | $160,000 | +272.1% | 65,941 | +326.2% | 0.00% | +100.0% |
| Q2 2018 | $43,000 | – | 15,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |